Pier 88 Investment Partners’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Pier 88 Investment Partners's BSX.PRA Position: Q2 2023 in Review
Pier 88 Investment Partners sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 90,935 shares — an estimated $11M sold.
Pier 88 Investment Partners first reported a position in BSX.PRA in Q2 2020 and held it in 7 quarters. The position peaked at $20.6M in Q4 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.
- Pier 88 Investment Partners reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
- Pier 88 Investment Partners sold 90,935 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $11M.
- Pier 88 Investment Partners first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 7 quarters.
- Pier 88 Investment Partners's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $20.6M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.
Based on Pier 88 Investment Partners's 13F filing for Q2 2023, filed 7 Aug 2023.